Key result
Fetal cardiac tumors are rare and usually benign, with prognosis depending on tumor characteristics and management options ranging from observation for spontaneous regression to invasive fetal surgery.
Fetal cardiac tumors are generally benign and may regress, but symptomatic cases require highly specialized, invasive management strategies.
Symptomatic fetal cardiac tumors may require specialized perinatal centers; leaves open need for prospective data on intervention timing and outcomes.
Fetal cardiac tumors are rare and usually benign. While echocardiography is a reliable technique for diagnosing fetal cardiac tumors, their definitive diagnosis relies on pathological examination. The strategies used to manage fetal cardiac tumors are challenging. A good clinical result is their complete regression during pregnancy or shortly after birth, as often occurs with cardiac rhabdomyomas. Moreover, the fetal prognosis depends on the nature of the tumors, namely, their location, size, number and associated complications. The active treatment options for symptomatic fetuses depend on the fetal status and may include fetal open surgery, postnatal tumor resection with or without the bridge of intrauterine pericardiocentesis, and thoracoamniotic shunting. The ex utero intrapartum treatment procedure provides an alternative technique for performing fetal open surgery and has shown promising preliminary results in selected cases, but is invasive for both the mother and fetus.
No takes yet. Share an insight, caveat, or question.
Shi‐Min Yuan (2017) conducted a review in Fetal cardiac tumors. Management strategies was evaluated. Fetal cardiac tumors are rare and usually benign, with prognosis depending on tumor characteristics and management options ranging from observation for spontaneous regression to invasive fetal surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: